Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Wuhan Xinhao Biotechnology is a specialized molecular diagnostics company based in Wuhan, China, focusing on the development and manufacture of in vitro diagnostic (IVD) solutions. The company provides a comprehensive range of products including nucleic acid extraction kits, PCR-based detection reagents, and automated diagnostic instruments. Their portfolio is particularly strong in infectious disease monitoring, featuring rapid detection kits for pathogens such as SARS-CoV-2 and Monkeypox virus. Wuhan Xinhao Biotechnology serves clinical laboratories, hospitals, and research institutions, emphasizing high sensitivity and specificity in its diagnostic tools. The company operates out of the East Lake High-tech Development Zone, also known as Optics Valley.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Wuhan Xinhao Biotechnology.